Abstract
In this review, we will summarize the guidelines on the evaluation of anticancer medicinal products in man and definitions for genomic biomarkers (FDA validated), pharmacogenomics, pharmacogenetics, genomic data and sample coding categories.
MeSH terms
-
Antineoplastic Agents / pharmacokinetics
-
Antineoplastic Agents / therapeutic use*
-
Biomarkers, Tumor / metabolism
-
Clinical Trials as Topic
-
Genetic Markers
-
Humans
-
Neoplasms / drug therapy*
-
Neoplasms / genetics
-
Neoplasms / metabolism
-
Practice Guidelines as Topic
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Genetic Markers